Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-10

Clinical Trial Update: Initial Combination With Pioglitazone Study (0431-064) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update describing the initial combination with pioglitazone for type 2 diabetes, with the study completed and results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-07-10